Search for: "T A V Holdings Inc" Results 9481 - 9500 of 12,078
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Oct 2019, 10:00 am by Eugene Volokh
Kentucky, 384 U.S. 195 (1966) (holding that Kentucky's common law crime of criminal libel was unconstitutionally void, as no court case had redefined the crime's sweeping language in understandable terms, leaving prosecution decisions to be made on a case to case basis);  see also Tollett v. [read post]
25 Oct 2021, 2:55 am by Peter Mahler
If ever there was a ticking time bomb of a family-owned, closely held business more likely to result in business divorce litigation than the one in Matter of Brady v Brady, 2021 NY Slip Op 02705 [4th Dept Apr. 30, 2021], I haven’t seen it. [read post]
21 Jul 2009, 3:25 pm by justinsilverman
With defamation by implication cases continuing to proceed and a holding like that in Noonan continuing to stand, I can’t help but to wonder if there is a trend against the truth building. [read post]
17 Jun 2024, 6:51 am by David Timm
Later my colleague Diana McGraw and I argued for it in Accura Eng’g & Consulting Servs., Inc. v. [read post]
17 Apr 2012, 5:55 pm by FDABlog HPM
” The Court says that its decision is consistent with the circumstances surrounding the aftermath of the Federal Circuit’s decision in Mylan Pharmaceuticals, Inc. v. [read post]
1 Jun 2018, 8:23 am by Eugene Volokh
The libel claims as to some of the other statements were dismissed largely on the grounds that the defendants sincerely believed they were true, so the court didn't have to decide whether or not they were opinion. [4.] [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]